Avalo Therapeutics Inc (AVTX)

Jun 05, 2025

Avalo Therapeutics Signs New Sales Agreement - TipRanks

Jun 05, 2025

Jun 04, 2025

Avalo Therapeutics Highlights AVTX-009 Potential in HS Market - TipRanks

Jun 04, 2025

Jun 04, 2025

Northern Trust Corp Invests $168,000 in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

Jun 04, 2025

Jun 03, 2025

Avalo Therapeutics (NASDAQ:AVTX) Upgraded at HC Wainwright - Defense World

Jun 03, 2025

Jun 02, 2025

H.C. Wainwright upgrades Avalo Therapeutics stock to buy - Investing.com

Jun 02, 2025

Jun 02, 2025

Avalo Therapeutics assumed with a Buy at H.C. Wainwright - TipRanks

Jun 02, 2025

Jun 02, 2025

H.C. Wainwright upgrades Avalo Therapeutics stock to buy By Investing.com - Investing.com South Africa

Jun 02, 2025

Jun 02, 2025

AVTX: Avalo Therapeutics Receives Buy Rating with $15 Target Pri - GuruFocus

Jun 02, 2025

Jun 02, 2025

Avalo Therapeutics (AVTX) Receives Buy Rating from H.C. Wainwright | AVTX Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

Cardax (OTCMKTS:CDXI) and Avalo Therapeutics (NASDAQ:AVTX) Head-To-Head Analysis - Defense World

Jun 02, 2025

May 31, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - Defense World

May 31, 2025

May 27, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferenc - GuruFocus

May 27, 2025

May 27, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

May 27, 2025

May 17, 2025

Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00 - Defense World

May 17, 2025

May 16, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Shares Bought by Tower Research Capital LLC TRC - Defense World

May 16, 2025

May 13, 2025

Strong Cash Position Secures AVTX Through 2027 | AVTX Stock News - GuruFocus

May 13, 2025

May 13, 2025

Avalo Therapeutics Reports Improved Financial Performance - TipRanks

May 13, 2025

May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire

May 12, 2025

May 12, 2025

Avalo Therapeutics reports Q1 EPS ($1.25) vs. ($141.14) last year - TipRanks

May 12, 2025

May 12, 2025

Avalo Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

May 12, 2025

Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025

May 12, 2025

AVTX Advances Phase 2 LOTUS Trial, Targets 2026 Data | AVTX Stoc - GuruFocus

May 12, 2025

May 12, 2025

AVALO THERAPEUTICS Earnings Results: $AVTX Reports Quarterly Earnings - Nasdaq

May 12, 2025

May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Bu - GuruFocus

May 12, 2025

May 12, 2025

Avalo Therapeutics Announces Leadership Change and Updates on AVTX-009 Phase 2 Trial for Hidradenitis Suppurativa - Nasdaq

May 12, 2025

May 12, 2025

Avalo Therapeutics, Inc. SEC 10-Q Report - TradingView

May 12, 2025

May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire Inc.

May 12, 2025

May 10, 2025

Avalo Therapeutics (AVTX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025

May 08, 2025

Avalo Therapeutics Updates on AVTX-009 and LOTUS Trial - TipRanks

May 08, 2025

May 07, 2025

15,323 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Acquired by Marshall Wace LLP - Defense World

May 07, 2025

May 06, 2025

When the Price of (AVTX) Talks, People Listen - news.stocktradersdaily.com

May 06, 2025

May 06, 2025

Avalo Therapeutics Enters $75 Million Sales Agreement With TD Cowen For Common Stock Offering - marketscreener.com

May 06, 2025

May 02, 2025

Geode Capital Management LLC Increases Position in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

May 02, 2025

Apr 30, 2025

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference - The Manila Times

Apr 30, 2025

Apr 23, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 20.3% in March - Defense World

Apr 23, 2025

Apr 22, 2025

60,000 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Purchased by Bank of Montreal Can - Defense World

Apr 22, 2025

Apr 22, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $33.00 Average PT from Brokerages - Defense World

Apr 22, 2025

Apr 16, 2025

Avalo Therapeutics (AVTX) Sees New Options Listings for April | AVTX Stock News - GuruFocus

Apr 16, 2025

Apr 16, 2025

Seven new option listings and one option delisting on April 16th - TipRanks

Apr 16, 2025

Apr 15, 2025

Avalo Therapeutics Reports 2024 Financial Results - TipRanks

Apr 15, 2025

Apr 09, 2025

Advanced Cancer Pain Management Therapeutics Market Size in 7MM - openPR.com

Apr 09, 2025

Apr 04, 2025

(AVTX) On The My Stocks Page - news.stocktradersdaily.com

Apr 04, 2025

Apr 04, 2025

AVTX stock touches 52-week low at $5.98 amid market challenges - Investing.com Australia

Apr 04, 2025

Apr 04, 2025

AVTX stock touches 52-week low at $5.98 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Mar 29, 2025

Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at Stifel Nicolaus - MarketBeat

Mar 29, 2025

Mar 28, 2025

Avalo Therapeutics (AVTX) to Release Earnings on Friday - Defense World

Mar 28, 2025

Mar 28, 2025

Analysts Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00 - Defense World

Mar 28, 2025

Mar 26, 2025

Avalo Therapeutics names new Chairman amid growth phase By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Avalo Therapeutics Names Michael Heffernan as Board Chairman - MarketScreener

Mar 26, 2025

Mar 26, 2025

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board - MarketScreener

Mar 26, 2025

Mar 26, 2025

Avalo Therapeutics names new Chairman amid growth phase - Investing.com

Mar 26, 2025